Catalytic Wealth Ria, LLC Novo Nordisk A S Transaction History
Catalytic Wealth Ria, LLC
- $545 Billion
- Q1 2025
A detailed history of Catalytic Wealth Ria, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 9,443 shares of NVO stock, worth $646,939. This represents 0.12% of its overall portfolio holdings.
Number of Shares
9,443
Previous 14,992
37.01%
Holding current value
$646,939
Previous $1.29 Billion
49.15%
% of portfolio
0.12%
Previous 0.23%
Shares
6 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.29 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.01 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$849 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$844 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$813 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $155B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...